Drug Infusion System Market is segmented By Product (Syringe Infusion Systems, Elastomeric Infusion Systems, Large Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic, Infusion Systems, Insulin Pumps, Others), By Product Placement (External, Implantable), By Portability (Fixed, Ambulatory), By Application (Oncotherapy, Diabetes, Analgesia, Nutrition, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Market Size in USD
CAGR8.9%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.9% |
Market Concentration | Medium |
Major Players | B. Braun Melsungen AG, Medtronic, BD (Becton, Dickinson and Company), Fresenius Kabi AG, Baxter |
The drug infusion system market is estimated to be valued at USD 12.77 Bn in 2024 and is expected to reach USD 25.15 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031. The market has been driven by rising prevalence of chronic diseases and growing need for safety, accuracy, and personalized care in drug delivery.